Company: PHAT
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034183
Chunk: 297

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 297
---
9
     
    10.1

    10.2#
     
    Form of Stock Option Grant Notice and Stock Option Agreement under the Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
     
    S-1
     
    9-30-2019
     
    10.2

    10.3#
     
    Form of Restricted Stock Grant Notice and Restricted Stock Agreement under Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan  
     
    S-1
     
    9-30-2019
     
    10.3

    10.4#
     
    Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan 
     
    S-1/A
     
    10-15-2019
     
    10.4

    10.5#
     
    Form of Stock Option Grant Notice and Stock Option Agreement under the Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan
     
    10-Q
     
    8-6-2020
     
    10.3

    10.6#
     
    Phathom Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan
     
    S-1/A
      
    10-15-2019
     
    10.5

    10.7#
     
    Amended and Restated Non-Employee Director Compensation Program
     
    10-Q
      
    8-8-2024
     
    10.1

147

    10.8#
     
    Amended and Restated Employment Letter Agreement, dated September 25, 2019, by and between Azmi Nabulsi, M.D., M.P.H. and the Registrant 
     
    S-1
     
    9-30-2019
     
    10.9

    10.9#
     
    Form of Indemnification Agreement for Directors and Officers 
     
    S-1
     
    9-30-2019
     
    10.11

    10.10†
     
    License Agreement, dated May 7, 2019, by and between Takeda Pharmaceuticals Company Limited and the Registrant
     
    S-1
     
    9-30